Linkage-To-Care: A Model for Success
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2017, Vol 4, Issue 1
Abstract
On July 13th 2010 the National HIV/AIDS Strategy (NHAS) set forth a goal of increasing national linkage to care rates from 65% to 85%. A local AIDS Services Organization (ASO) that recently transitioned to a Federally Qualified Health Center (FQHC) in New Orleans, LA, USA had a testing cohort of 2,785 with a consistent 2% positivity rate. Prior to hiring a dedicated Patient Navigator in 2012, agency linkage to care rates hovered around 50%. This article charts how the agency increased its linkage to care rate by 40% over the course of three years and will examine inputs, strategies and best practices of a successful linkage-to-care model implemented in New Orleans, LA, USA.
Authors and Affiliations
Ashley King
Keywords
Related Articles
- EP ID EP555356
- DOI 10.17140/HARTOJ-4-122
- Views 122
- Downloads 0
Preventable Deaths among HIV-Positive Patients: A Real-Life Perspective from a Teaching Hospital in Northern Mexico
Introduction Antiretroviral therapy (ART) in patients infected with human immunodeficiency virus (HIV) are more effective and better tolerated and for this reason the gap between life expectancy of an HIV-seropositive in...
Relationship between Knowledge of Someone Infected With HIV/AIDS and HIV Stigma: A Moderated Mediation Model of HIV Knowledge, Gender and HIV Test Uptake
Introduction: Sub-Saharan Africa has been particularly impacted by the HIV epidemic with an estimated 24.7 million out of 36.9 million people living with HIV/AIDS (PLWH). Nigeria has the second highest number of people l...
HIV Infection on the Rise among Chinese College Students
From the early 1980s when it was identified in 2017, the human immunodeficiency virus (HIV) has infected an estimated 78 million people around the world, causing an estimated 35 million acquired immune deficiency syndrom...
Why Novel Nanoparticle-based Delivery Platforms Hold Key for HIV/AIDS Treatment and Prevention?
The administration of highly active antiretroviral therapy (HAART) to HIV/AIDS patients has greatly reduced their morbidity and mortality. However, HAART regimens have myriad of limitations, which make it difficult to co...
The HIV-2 SU Glycoprotein Influence Proviral Integration Dynamics into Human CD4+ T-Lymphocytes
Primary and chimeric Human Immunodeficiency Virus type 2 (HIV-2), co-receptor usage, cDNA integration and, pathogenesis are mechanisms still poorly understood. However, these features seem to be related to a flexible env...